Literature DB >> 19508391

Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation.

Feng Wu1, Min Han, John X Wilson.   

Abstract

BACKGROUND AND
PURPOSE: Tripterine is an inhibitor of heat shock protein 90 and an active component of Tripterygium wilfordii Hook F., which is used in traditional Chinese medicine to treat inflammatory diseases such as rheumatoid arthritis. We hypothesized that tripterine inhibits endogenous peroxynitrite formation and thereby prevents endothelial barrier dysfunction. EXPERIMENTAL APPROACH: Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phasphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkappaB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon gamma (IFNgamma)] and on vascular permeability in air pouches of mice injected with LPS + IFNgamma. KEY
RESULTS: LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM). Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. CONCLUSION AND IMPLICATIONS: Our results indicate that, by preventing Jak2-dependent induction of iNOS and Nox1, tripterine inhibits peroxynitrite precursor synthesis, attenuates the increased activity of PP2A and consequently protects endothelial barrier function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508391      PMCID: PMC2737660          DOI: 10.1111/j.1476-5381.2009.00292.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  59 in total

Review 1.  Regulation of the expression of inducible nitric oxide synthase.

Authors:  Hartmut Kleinert; Andrea Pautz; Katrin Linker; Petra M Schwarz
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

2.  Differential nitric oxide production by microvascular and macrovascular endothelial cells.

Authors:  M Geiger; A Stone; S N Mason; K T Oldham; K S Guice
Journal:  Am J Physiol       Date:  1997-07

3.  Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung.

Authors:  C E Patterson; R A Rhoades; J G Garcia
Journal:  J Appl Physiol (1985)       Date:  1992-03

4.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.

Authors:  Haley Hieronymus; Justin Lamb; Kenneth N Ross; Xiao P Peng; Cristina Clement; Anna Rodina; Maria Nieto; Jinyan Du; Kimberly Stegmaier; Srilakshmi M Raj; Katherine N Maloney; Jon Clardy; William C Hahn; Gabriela Chiosis; Todd R Golub
Journal:  Cancer Cell       Date:  2006-09-28       Impact factor: 31.743

5.  Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.

Authors:  Jeong-Hyung Lee; Tae Hyeon Koo; Hyunkyung Yoon; Haeng Sun Jung; Hui Zi Jin; Kyeong Lee; Young-Soo Hong; Jung Joon Lee
Journal:  Biochem Pharmacol       Date:  2006-09-18       Impact factor: 5.858

6.  Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells.

Authors:  Feng Wu; David P Schuster; Karel Tyml; John X Wilson
Journal:  Free Radic Biol Med       Date:  2006-10-06       Impact factor: 7.376

7.  Mechanisms of H2O2-induced oxidative stress in endothelial cells exposed to physiologic shear stress.

Authors:  Christian H Coyle; Khalid N Kader
Journal:  ASAIO J       Date:  2007 Jan-Feb       Impact factor: 2.872

8.  Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.

Authors:  George P Sorescu; Hannah Song; Sarah L Tressel; Jinah Hwang; Sergey Dikalov; Debra A Smith; Nolan L Boyd; Manu O Platt; Bernard Lassègue; Kathy K Griendling; Hanjoong Jo
Journal:  Circ Res       Date:  2004-09-23       Impact factor: 17.367

9.  c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages.

Authors:  Aleksi Lahti; Ulla Jalonen; Hannu Kankaanranta; Eeva Moilanen
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

10.  Ascorbate uptake by microvascular endothelial cells of rat skeletal muscle.

Authors:  J X Wilson; S J Dixon; J Yu; S Nees; K Tyml
Journal:  Microcirculation       Date:  1996-06       Impact factor: 2.628

View more
  13 in total

Review 1.  Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.

Authors:  Cong-Ying Song; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

2.  NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action.

Authors:  Vincent Jaquet; Julien Marcoux; Eric Forest; Kevin G Leidal; Sally McCormick; Yvonne Westermaier; Remo Perozzo; Olivier Plastre; Laetitia Fioraso-Cartier; Becky Diebold; Leonardo Scapozza; William M Nauseef; Franck Fieschi; Karl-Heinz Krause; Karen Bedard
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.

Authors:  Ying Wang; Lu Cao; Li-Min Xu; Fan-Fan Cao; Bin Peng; Xue Zhang; Yu-Fan Shen; Georges Uzan; Deng-Hai Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-15       Impact factor: 4.147

4.  Tripterygium polyglycosid attenuates the established airway inflammation in asthmatic mice.

Authors:  Chang-Gui Chen; Hui-Ying Wang; Yu Dai; Jiao-Li Wang; Wei-Hua Xu
Journal:  Chin J Integr Med       Date:  2013-01-15       Impact factor: 1.978

Review 5.  Evaluation of vitamin C for adjuvant sepsis therapy.

Authors:  John X Wilson
Journal:  Antioxid Redox Signal       Date:  2013-06-25       Impact factor: 8.401

6.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  A lipidomics investigation into the intervention of celastrol in experimental colitis.

Authors:  Renping Wang; Xueqin Gu; Weiquan Dai; Jun Ye; Feng Lu; Yifeng Chai; Guorong Fan; Frank J Gonzalez; Gengli Duan; Yunpeng Qi
Journal:  Mol Biosyst       Date:  2016-04-26

8.  The effects of inflammatory cytokines on lymphatic endothelial barrier function.

Authors:  Walter E Cromer; Scott D Zawieja; Binu Tharakan; Ed W Childs; M Karen Newell; David C Zawieja
Journal:  Angiogenesis       Date:  2013-10-20       Impact factor: 9.596

Review 9.  NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS.

Authors:  Eugenia Cifuentes-Pagano; Gabor Csanyi; Patrick J Pagano
Journal:  Cell Mol Life Sci       Date:  2012-05-15       Impact factor: 9.261

Review 10.  NADPH oxidases in vascular pathology.

Authors:  Anna Konior; Agata Schramm; Marta Czesnikiewicz-Guzik; Tomasz J Guzik
Journal:  Antioxid Redox Signal       Date:  2013-11-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.